Stem Cell Transplantation Offering Long-Term Remission Opportunities Stem cell transplantation remains a key treatment approach within the Acute Myeloid Leukemia Treatment Market, particularly for patients at high risk of relapse. After achieving remission through chemotherapy or targeted therapy, eligible patients may undergo transplantation to replace diseased bone marrow. Healthy donor stem cells restore normal blood production and help eliminate remaining leukemia cells. Ref - https://www.marketresearchfuture.com/reports/acute-myeloid-leukemia-treatment-market-3223